Login / Signup

Assessing the external validity of the VALIDATE-SWEDEHEART trial.

Rebecca Tremain RylancePhilippe WagnerElmir OmerovicClaes HeldStefan JamesSasha KoulDavid Erlinge
Published in: Clinical trials (London, England) (2021)
The propensity score difference demonstrated that the screened not-enrolled with fulfilled inclusion criteria and trial population were not similar. The inverse-probability weighted analysis showed no significant differences in mortality. From this, we conclude that the VALIDATE results may be generalized to the screened not-enrolled with fulfilled inclusion criteria.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • magnetic resonance
  • cardiovascular events
  • randomized controlled trial
  • open label
  • contrast enhanced
  • computed tomography
  • network analysis